Correlation Between N Able and Enfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both N Able and Enfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining N Able and Enfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between N Able Inc and Enfusion, you can compare the effects of market volatilities on N Able and Enfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in N Able with a short position of Enfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of N Able and Enfusion.

Diversification Opportunities for N Able and Enfusion

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between NABL and Enfusion is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding N Able Inc and Enfusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enfusion and N Able is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on N Able Inc are associated (or correlated) with Enfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enfusion has no effect on the direction of N Able i.e., N Able and Enfusion go up and down completely randomly.

Pair Corralation between N Able and Enfusion

Given the investment horizon of 90 days N Able Inc is expected to under-perform the Enfusion. But the stock apears to be less risky and, when comparing its historical volatility, N Able Inc is 1.32 times less risky than Enfusion. The stock trades about -0.15 of its potential returns per unit of risk. The Enfusion is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  808.00  in Enfusion on August 15, 2024 and sell it today you would earn a total of  142.00  from holding Enfusion or generate 17.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

N Able Inc  vs.  Enfusion

 Performance 
       Timeline  
N Able Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days N Able Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Enfusion 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.

N Able and Enfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with N Able and Enfusion

The main advantage of trading using opposite N Able and Enfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if N Able position performs unexpectedly, Enfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will offset losses from the drop in Enfusion's long position.
The idea behind N Able Inc and Enfusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges